MentionFox
Home › Stakes › Iradimed Corp
5%+ stakes · Schedule 13D and 13G

Iradimed Corp: 5%+ holders

Before you sign with, sell to or invest in Iradimed Corp

MentionFox check on Iradimed Corp: no red flags found in 4 sources (checked 6 November 2026). mentionfox.com/c/stakes/iradimed

Check Iradimed Corp before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Iradimed Corp?

Who has reported owning 5% or more of Iradimed Corp, from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Iradimed Corp. The largest reported stake is Roger E. Susi's, at 34.8%. 4 filings are on record since February 10, 2026 (Schedule 13G/A, May 14, 2026).

BlackRock, Inc. also filed stake reports on 1596 other companies ↓

Sell to companies like Iradimed Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · Reporting person: BlackRock, Inc. · Sole voting: 614,615 · Shared voting: 0 · Sole dispositive: 634,738 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-10-27
  • · Holder: BlackRock, Inc. · Percent: 5.01% · SCHEDULE 13G
  • · Reporting person: Roger E. Susi · Sole voting: 162,950 · Shared voting: 4,287,500 · Sole dispositive: 162,950 · Shared dispositive: 4,287,500 · SCHEDULE 13G/A, 2026-05-14
  • · Reporting person: Nine Ten Capital Management · Sole voting: 428,477 · Sole dispositive: 428,477 · SCHEDULE 13G/A, 2026-02-10
At 5% or more1
Filings4
Latest filing2026-10-27

Iradimed Corp has 4 Schedule 13D or 13G filings on record since 2026-02-10. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
34.8%4,450,450SCHEDULE 13G/A, 2026-05-142026-03-31
BlackRock, Inc.4.96%634,738SCHEDULE 13G/A, 2026-10-272026-09-30
Nine Ten Capital Management3.4%428,477SCHEDULE 13G/A, 2026-02-102025-12-31

Holding shares or following this stake? See who's behind Iradimed Corp and the warning signs.

Free to see. No signup.

Keep reading

More on Iradimed Corp and the records around it.

Iradimed Corp elsewhere on the record

Companies that share a holder

Want the whole picture on Iradimed Corp?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Iradimed Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Iradimed Corp covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    4 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Roger E. Susi162,9504,287,500162,9504,287,500SCHEDULE 13G/A, 2026-05-14
Roger E. Susi Revocable Trust162,9500162,9500SCHEDULE 13G/A, 2026-05-14
Matthew Susi 2008 Dynasty Trust2,062,50002,062,5000SCHEDULE 13G/A, 2026-05-14
Phillip Susi 2008 Dynasty Trust2,225,00002,225,0000SCHEDULE 13G/A, 2026-05-14
J. Richard Susi04,287,50004,287,500SCHEDULE 13G/A, 2026-05-14
BlackRock, Inc.614,6150634,7380SCHEDULE 13G/A, 2026-10-27
Nine Ten Capital Management428,477—428,477—SCHEDULE 13G/A, 2026-02-10
Nine Ten Partners LP428,477—428,477—SCHEDULE 13G/A, 2026-02-10
Russell Mollen428,477—428,477—SCHEDULE 13G/A, 2026-02-10

The latest filing identifies Iradimed Corp by CUSIP 46266A109 and gives its principal executive office as 12705 Ingenuity Drive, Orlando, FL 32826 (SCHEDULE 13G/A, 2026-10-27).

What the percentages are based on

Each of the Reporting Persons may be deemed to be the beneficial owner of the percentage of shares of Common Stock listed on such Reporting Person's cover page, calculated under Rule 13d-3 of the Securities Exchange Act of 1934, as amended.Roger E. Susi, SCHEDULE 13G/A, 2026-05-14

Timeline

FiledHolderPercentFiling
2026-02-10Nine Ten Capital Management3.4%SCHEDULE 13G/A
2026-05-14Roger E. Susi34.8%SCHEDULE 13G/A
2026-07-28BlackRock, Inc.5.01%SCHEDULE 13G
2026-10-27BlackRock, Inc.4.96%SCHEDULE 13G/A

Questions about who owns Iradimed Corp

Who owns Iradimed Corp?

On this page, one holder's latest ownership filing reports 5% or more of Iradimed Corp: Roger E. Susi (34.8%, Schedule 13G/A, filed 2026-05-14).

When did Roger E. Susi buy into Iradimed Corp?

The filings give report dates, not purchase dates. The earliest filing from Roger E. Susi on this page is the Schedule 13G/A, filed 2026-05-14, reporting 34.8%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Tools for this story

Each opens in a new tab, filled in for Iradimed Corp. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/iradimed
Last updated 2026-11-06
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who owns 5% or more of Iradimed Corp? 1 holder at 5% or more, largest Roger E. Susi 34.8%. MentionFox, 2026-11-06. https://mentionfox.com/stakes/iradimed